Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery

Author： Roger Emilie   Lagarce Frederic   Garcion Emmanuel   Benoit Jean-Pierre  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.5, Iss.2, 2010-02, pp. : 287-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanocarriers for vascular delivery of antioxidants

By Hood Elizabeth   Simone Eric   Wattamwar Paritosh   Dziubla Thomas   Muzykantov Vladimir  

Nanomedicine, Vol. 6, Iss. 7, 2011-09 ,pp. : 1257-1272

Future Medicine

Access to resources Recommend Favorite

Nanovaccines : nanocarriers for antigen delivery

By Gonzalez-Aramundiz Jose Vicente   Cordeiro Ana Sara   Csaba Nœmi   de la Fuente Maria   Alonso María José  

Biologie Aujourd'hui, Vol. 206, Iss. 4, 2013-02 ,pp. : 249-261

Edp Sciences

Access to resources Recommend Favorite

Characterization of hyperbranched core‐multishell nanocarriers as an innovative drug delivery system for the application at the oral mucosa

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 53, Iss. 1, 2018-02 ,pp. : 57-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel alginate-enclosed chitosan–calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy

By Kanwar Jagat R   Mahidhara Ganesh   Kanwar Rupinder K  

Nanomedicine, Vol. 7, Iss. 10, 2012-10 ,pp. : 1521-1550

Future Medicine

Access to resources Recommend Favorite

Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery

By  

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 71-86

Bentham Science Publishers

Access to resources Recommend Favorite